Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
In Table 2 of the original publication, there were errors in the baseline scores for the PedsQL TM 3.0 Cancer Module questionnaire, so a corrected version of Table 2 is shown in this erratum. In the subcategories of the PedsQL TM 3.0 Cancer Module questionnaire, nausea and fear of procedure did not score significantly lower after treatment compared to baseline. So, based on the corrected data in Table 2, there was no significant decrease in the total score of the cancer questionnaire, and this statement in the previous manuscript was incorrect.
|Persistent URL||dx.doi.org/10.1007/s11060-017-2636-0, hdl.handle.net/1765/102542|
|Journal||Journal of Neuro-Oncology|
Veldhuijzen Van Zanten, S.E.M, El‑Khouly, F.E. (Fatma E.), Jansen, M, Bakker, D.P. (Dewi P.), Aliaga, E.S, Haasbeek, C.J.A, … Kaspers, G.J. (2017). Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma. Journal of Neuro-Oncology, 1–2. doi:10.1007/s11060-017-2636-0